This could be the best news ever in the history of clinical drug development for PSP. Last week, I attended the Global Tau meeting in London as a representative of CurePSP. Plenty of excellent research was presented, but most of it was laboratory work that would be difficult to relate to the direct concerns of … Continue reading Two new drugs get a platform